The Division of Allergy and Infectious Diseases at the University of Washington has trained 115 physician-scientists through continuous funding provided by this training grant since its inception in 1976. More than 85% of these trainees remain in research positions. Many have achieved leadership positions such as two that became Deans of Medicine, one that became a Department Chair, 7 that became Division Heads, and 17 others with leadership positions. Trainees that have completed in the past 10 years have had remarkable early success in research careers, including >75% achieving research funding, >50% with K awards, and >90% publishing one or more papers related to their supported research. The continuing objective of the program is to provide post-doctoral training for physician-scientists committed to an academic career in infectious diseases, with particular emphasis on research training. Each trainee selects a mentor for detailed research training in one of six research tracks. All trainees complete a core curriculum consisting of required didactic, research and clinical activities. Many trainees elect to take course work at the University of Washington and an average of two a year seek a MPH or MSc award. The program generally requires three years of training, two of which are supported by this training grant.
Infectious diseases continue to extract a considerable social and financial toll even in developed countries due to factors such as emerging pathogens, AIDS or other immuno-compromising conditions and antimicrobial resistance;in fact, they represent the leading cause of morbidity and mortality worldwide. The training of new scientists-physicians who can elucidate the basic mechanisms of host defense is critical for the formulation of new and improved strategies to diagnose, treat and prevent infectious diseases.
|Adams, Kristin N; Szumowski, John D; Ramakrishnan, Lalita (2014) Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs. J Infect Dis 210:456-66|
|Hill, J A; Myerson, D; Sedlak, R H et al. (2014) Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. Transpl Infect Dis 16:477-83|
|Zaniello, Benjamin; Phillips-Caesar, Erica (2014) Over-the-counter medication overuse and bowel obstruction. J Am Geriatr Soc 62:400-2|
|Fisher, C E; Stevens, A M; Leisenring, W et al. (2014) Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis. Transpl Infect Dis 16:505-10|
|Fisher, Cynthia E; Boeckh, Michael; Hohl, Tobias M (2014) Reply to King and Stover. Clin Infect Dis 58:752|
|Zaniello, Ben A; Gottlieb, Geoffrey S (2014) A 58-year-old immunosuppressed male with chronic cough, diarrhea, and a new "pressure" ulcer. J Clin Microbiol 52:1, 382|
|Fisher, Cynthia E; Stevens, A Michal; Leisenring, Wendy et al. (2013) The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis 57:1001-4|
|Chu, Helen Y; Kuypers, Jane; Renaud, Christian et al. (2013) Molecular epidemiology of respiratory syncytial virus transmission in childcare. J Clin Virol 57:343-50|
|Li, Hui; Hughes, Austin L; Bano, Nazneen et al. (2011) Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time. PLoS One 6:e19562|
|Scott, John D; Wald, Anna; Kitahata, Mari et al. (2009) Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population. AIDS Patient Care STDS 23:925-9|
Showing the most recent 10 out of 58 publications